PD
PD-Rx Pharmaceuticals, Inc.
PDRX · OTC
$3.10 +0.00% (+$0.00)
Market Cap $5.32M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$4.27
37.7% upside
Current Price
$3.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PDRX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Valuation
100 /100
Cheap P/S 0.29x
P/B 0.52x
P/FCF 6.97x
Growth
1 /100
Declining Rev. growth 13.87%
FCF growth 34.27%
Book val. growth 3.38%
Profitability
10 /100
Weak Gross margin 0.00%
Net margin 1.40%
Op. margin 2.60%
Quality
50 /100
Average ROA 2.15%
Asset turnover 1.53x
ROIC N/A
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 6.34x
Int. coverage N/A
Stability
26 /100
Unstable Beta 1,696,040.77x
Rev. volatility 11.57%
EPS volatility 382.44%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PDRX
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert D. Holsey
Employees
142
Headquarters
Oklahoma City